BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7486211)

  • 21. Bartter's syndrome: contrasting patterns of prostaglandin excretion in children and adults.
    Dray F
    Clin Sci Mol Med; 1978 Jan; 54(1):115-8. PubMed ID: 620489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide in IgA nephropathy patients with or without hypertension.
    Kovács T; Barta J; Kocsis B; Nagy J
    Exp Nephrol; 1995; 3(6):369-72. PubMed ID: 8528682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
    Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
    Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypokalemia and hypoevolutism. Description of a case of Bartter's syndrome].
    Demi M; Grassi N; Mastella M
    Pediatr Med Chir; 1989; 11(6):717-9. PubMed ID: 2636384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low urinary calcium excretion in Bartter's syndrome.
    Rudin A; Sjögren B; Aurell M
    N Engl J Med; 1984 May; 310(18):1190. PubMed ID: 6709017
    [No Abstract]   [Full Text] [Related]  

  • 28. Resistance to endogenous norepinephrine in Bartter's syndrome: reversion during indomethacin administration.
    Silverberg AB; Mennes PA; Cryer PE
    Am J Med; 1978 Feb; 64(2):231-5. PubMed ID: 629272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bartter's syndrome, hypomagnesaemia and chondrocalcinosis.
    de Heide LJ; Birkenhäger JC
    Neth J Med; 1991 Oct; 39(3-4):148-52. PubMed ID: 1791876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenomedullin and nitrite levels in children with Bartter syndrome.
    Balat A; Cekmen M; Yürekli M; Kutlu O; Islek I; Sönmezgöz E; Cakir M; Türköz Y; Yoloğlu S
    Pediatr Nephrol; 2000 Dec; 15(3-4):266-70. PubMed ID: 11149123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bartter's syndrome: an autosomal recessive disorder? Study of four patients in one generation of the same pedigree and their relatives.
    Hogewind BL; van Brummelen P; Veltkamp JJ
    Acta Med Scand; 1981; 209(6):463-7. PubMed ID: 7257865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
    Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
    J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bartter's and Gitelman's syndromes: from gene to clinic.
    Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
    Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hyperprostaglandin E syndrome: a hypercalciuric variant of Bartter's syndrome.
    Welch TR
    J Bone Miner Res; 1997 Oct; 12(10):1753-4. PubMed ID: 9333138
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood and extracellular fluid volume in patients with Bartter's syndrome.
    Boer P; Hené RJ; Koomans HA; Nieuwenhuis MG; Geyskes GG; Mees EJ
    Arch Intern Med; 1983 Oct; 143(10):1902-5. PubMed ID: 6625776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
    Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
    J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome.
    Yoshida H; Kakuchi J; Yoshikawa N; Saruta T; Inagami T; Phillips JA; Ichikawa I
    Kidney Int; 1994 Dec; 46(6):1505-9. PubMed ID: 7699991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bartter's syndrome--hypokalemic renal tubular syndrome].
    Gazdíková K; Gazdík F
    Cas Lek Cesk; 2003 Aug; 142(8):474-8. PubMed ID: 14626562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.